At the meeting, which highlighted the latest in clinical and translational genomics research, Phung presented an oral abstract on her lab’s research in vascular anomalies.
Phung also led an interactive roundtable discussion on practical approaches to establishing molecular diagnostics in community hospitals and smaller laboratory settings. She shared her insight and perspective from working to establish molecular cancer testing at USA Health. One participant gave the feedback: “I really appreciate your leading the roundtable discussion today, and was excited to hear about your passion for bringing molecular testing to underserved and underrepresented areas.”Phung, who served on the annual meeting program committee, helped to organize the meeting and its contents. Other topics presented at the meeting included the next generation of cytogenetics and molecular genetics in leukemia diagnostics, and artificial intelligence applications to drive precision oncology clinical trials.
